Wafa Abdulsamad, Moassass Faten, Liehr Thomas, Bhatt Samarth, Aljapawe Abdulmunim, Al Achkar Walid
Human Genetics Division, Department of Molecular Biology and Biotechnology, Atomic Energy Commission of Syria, P.O. Box 6091, Damascus, Syria.
Jena University Hospital, Institute of Human Genetics, Kollegiengasse 10, D-07743 Jena, Germany.
Mol Cytogenet. 2016 Dec 20;9:91. doi: 10.1186/s13039-016-0300-6. eCollection 2016.
Follicular lymphoma (FL) is one of the most common B-cell non-Hodgkin's lymphoma (NHL). A subset of FL cases transform into more aggressive malignancies, most often to diffuse large B-cell lymphoma (DLBCL); in addition, lymphoblastic lymphoma and acute lymphoblastic leukemia (ALL) have also been rarely reported. The most common cytogenetic abnormalities associated with FL are translocation t(14;18)(q32;q21) with rearrangements, present in 80-90% of all FL. However, that translocation alone is insufficient to cause FL and additional genomic events specifically leading to this kind of disease are still to be determined. The most frequently reported secondary changes are gains of chromosomes 7p or 7q, Xp, 12q and 18q, as well as losses on 6q and mutations within and/or genes. The presence of additional genomic aberrations, in particular 17p and 6q deletions is more frequent in grade 2 and 3 FL patients and correlated with shorter survival and a higher rate of transformation into DLBCL.
We describe here, an adult FL grade 2 patient that had transformed to B-ALL at diagnosis. Banding cytogenetics, refined by multi-color fluorescence in situ hybridization including array-proven multicolor banding revealed a unique complex karyotype involving eleven chromosomes, translocation t(X;20)(p21.3;q11.2), translocation t(3;20)(q26.2;q12), and a dicentric dic(17;18). Interestingly, the dicentric chromosome led to monosomy of the tumor suppressor gene TP53. The case had an immunophenotype consistent with follicular center cell lymphoma according to the World Health Organization (WHO) recommendations.
To the best of our knowledge, a comparable adult FL grade 2 case that transformed to B-ALL associated with such a complex karyotype and loss of was not previously reported. Most of complex aberrations were found simultaneously in approximately 85% of studied malignant cells and the remained cells studied were non-clonal; mechanisms explaining this may be either multiple-step mechanisms or single step in sense of chromothripsis.
Identifying number: 3842. Registered 09 July 2012.
滤泡性淋巴瘤(FL)是最常见的B细胞非霍奇金淋巴瘤(NHL)之一。一部分FL病例会转化为侵袭性更强的恶性肿瘤,最常见的是弥漫性大B细胞淋巴瘤(DLBCL);此外,也有罕见报道称会转化为淋巴母细胞淋巴瘤和急性淋巴细胞白血病(ALL)。与FL相关的最常见细胞遗传学异常是14号和18号染色体易位t(14;18)(q32;q21) 及重排,在所有FL病例中占80 - 90%。然而,仅这种易位不足以引发FL,导致这种疾病的其他基因组事件仍有待确定。最常报道的继发性改变是7p或7q、Xp、12q和18q染色体的增加,以及6q的缺失和 和/或 基因内的突变。在2级和3级FL患者中,额外基因组畸变尤其是17p和6q缺失的情况更常见,且与较短生存期及更高的转化为DLBCL的发生率相关。
我们在此描述一名成年2级FL患者,其在诊断时已转化为B - ALL。通过多色荧光原位杂交(包括经阵列验证的多色带型分析)优化的染色体显带分析显示了一种独特的复杂核型,涉及11条染色体、易位t(X;20)(p21.3;q11.2)、易位t(3;20)(q26.2;q12),以及一条双着丝粒染色体dic(17;18)。有趣的是,这条双着丝粒染色体导致了肿瘤抑制基因TP53的单体性。根据世界卫生组织(WHO)的建议,该病例的免疫表型与滤泡中心细胞淋巴瘤一致。
据我们所知,此前尚未报道过类似的成年2级FL病例转化为B - ALL并伴有如此复杂核型及 缺失的情况。在大约85%的研究恶性细胞中同时发现了大多数复杂畸变,其余研究细胞为非克隆性;对此的解释机制可能是多步骤机制或类似于染色体碎裂的单步骤机制。
识别号:3842。于2012年7月9日注册。